STOCKSURGICAL & MEDICAL INSTRUMENTS & APPARATUSUpdated 2026-08-23
Here’s whether Medline Inc. Class A common stock (MDLN) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-0.30% over 10 days); 3-month momentum negative (-7.4%). Currently 32.7% off its 52-week high. Score: -3/7.
MDLN is trading below its 200-day MA (—) — a key warning sign the longer-term trend is under pressure. An RSI of 32.8 sits in the neutral zone — momentum is neither stretched nor exhausted. With ~8 months of trading history, the return since first available bar is -16.4%. The current 32.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 8 months ago→ $8,356 today
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 100-day MA ($39.60)
✗Above 25-day MA ($36.98)
✓RSI(10) neutral zone (30–70) — currently 44.1
✗Positive return (-31.0%)
!Within 10% of period high (−32.7%)
Period Range $34.26
$32.49$50.88
RSI (10) 44.1
0 · OversoldOverbought · 100
Key Metrics
Price$34.26
Period Return-31.0%
Period High$50.88
Period Low$32.49
Drawdown−32.7%
MA-25$36.98
MA-100$39.60
RSI (10)44.1
Avg Volume (30d)6.8M
vs. SPYtrailed by 43.2%
Trend Signals
Price is below the 100-day moving average ($39.60)